SOLVSolventum CorporationHealthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $88.83 · now $88.83 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, SOLV has typically landed between $77.79 and $101.96 — a range of −12.4% to +14.8% from the issuance price $88.83.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

600 overlapping 1 month windows · 2024-03-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($88.83) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where SOLV has typically landed a month from the 2026-09-16 close of $88.83 — the range is history, not a prediction.

$77.79worst · -12.4%$101.96best · +14.8%
  • now $88.83 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $89.61 (+0.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $84.37$94.85
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $77.79$101.96
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 600 windows spanning 2024-03-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2024-03-26−22.7%−22.9%+0.0%
2025-03-10−18.8%−18.8%+0.0%
2026-02-26−18.4%−18.4%+0.0%
3 best
2025-11-05+26.2%−2.1%+26.7%
2025-11-03+25.1%−2.7%+25.9%
2025-11-06+24.6%+0.0%+29.4%

600 overlapping windows · 2024-03-262026-09-16 · not cherry-picked

Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.

$13.5B
market cap
$8.17
EPS (TTM)
9.5
P/E (TTM)
2026-08-05
next earnings
Revenue$8.3B
'20'25
Net income$1.6B
'20'25
Free cash flow−$10M
'20'25
Net margin · by yr18.7%
'20'25
ROE · by yr30.8%
'20'25
Debt / equity · by yr1.00
'20'25

Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.

iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 54 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.
now $88.83$28.50$238.68
  • DCF (intrinsic)$142.09
  • Peer P/E × EPS · sector median 27.4× · n=54$224.19
  • Analyst target · range $43.00$94.00$90.50
  • Current price · last close 2026-09-16$88.83

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~3 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
+4.6%
n=2
Feb
50%
+2.0%
n=2
Mar
0%
−8.3%
n=2
Apr
33%
−5.5%
n=3
May
67%
+4.4%
n=3
Jun
67%
−1.4%
n=3
Jul
67%
+5.4%
n=3
Aug
100%
+6.0%
n=3
Sep
33%
+2.1%
n=3
Oct
50%
−0.7%
n=2
Nov
50%
+11.0%
n=2
Dec
0%
−7.3%
n=2

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$92$622026-03-10: 1 insider purchase, $100K — Wendell Amy McBride2025-08-15: 1 insider sale, $646.4M — 3M CO2025-08: 1 open-market sale, $646.4M2026-03: 1 open-market purchase, $100K↑ buys↓ salesdirector Wendell Amy McBride — Purchase on 2026-03-10, filed 1 day after the tradetenPercentOwner 3M CO — Sale on 2025-08-15, filed 3 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-03-10Wendell Amy McBridedirectorPurchase1,475 @ $68.03$100K+41.4% of holding−2.8%+20.0%5,039Form 4 · filed 1 day after the trade
2025-08-153M COtenPercentOwnerSale8,800,000 @ $73.45$646.4M−25.6% of holding+1.2%−3.5%25,569,190Form 4 · filed 3 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

205 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-01Hanson Bryan CdirectorWithheld for tax26,468185,515Form 4
2026-09-01Hanson Bryan CdirectorOption exercise67,2610Form 4
2026-09-01Hanson Bryan CdirectorOption exercise67,261211,983Form 4
2026-09-01Hanson Bryan CdirectorOption exercise67,261211,983Form 4
2026-09-01Hanson Bryan CdirectorOption exercise67,261211,983Form 4
2026-09-01Hanson Bryan CdirectorOption exercise67,261211,983Form 4
2026-08-17Zieselman Neil CraigofficerAward / grant6,9116,911Form 4
2026-05-15COX CARRIE SMITHdirectorAward / grant4,8484,848Form 4
2026-05-15ALBAN CARLOSdirectorAward / grant3,3003,300Form 4
2026-05-15Edwards Shirley AnndirectorAward / grant3,3003,300Form 4
2026-05-15EISENBERG GLENN AdirectorAward / grant3,3003,300Form 4
2026-05-15Harris Bernard A JrdirectorAward / grant3,3003,300Form 4
2026-05-15Wendell Amy McBridedirectorAward / grant3,3003,300Form 4
2026-05-15Wilson Darryl L.directorAward / grant3,3003,300Form 4
2026-05-15Mily ElizabethdirectorAward / grant3,3003,300Form 4
2026-05-15MAY KAREN JdirectorAward / grant3,3003,300Form 4
2026-05-15WEILAND JOHN HdirectorAward / grant3,3003,300Form 4
2026-05-15DeVore Susan D.directorAward / grant3,3003,300Form 4
2026-05-13Hanson Bryan CdirectorWithheld for tax13,503144,722Form 4
2026-05-13McMillan Wayde D.directorWithheld for tax4,40448,637Form 4
2026-05-13Landucci AmyofficerWithheld for tax2,01739,888Form 4
2026-05-13Kirberger Marcela A.officerWithheld for tax1,95213,540Form 4
2026-05-13Harrington Paul SofficerWithheld for tax1,67820,452Form 4
2026-05-13Gomez Tammy LofficerWithheld for tax1,66813,362Form 4
2026-05-13Wilcox Mary TofficerWithheld for tax7286,904Form 4
2026-05-13McMillan Wayde D.directorOption exercise9,50353,041Form 4
2026-05-13Hanson Bryan CdirectorOption exercise34,315158,225Form 4
2026-05-13Harrington Paul SofficerOption exercise3,9603,960Form 4
2026-05-13McMillan Wayde D.directorOption exercise9,5039,504Form 4
2026-05-13Wilcox Mary TofficerOption exercise2,3767,632Form 4
2026-05-13Wilcox Mary TofficerOption exercise2,3762,377Form 4
2026-05-13Landucci AmyofficerOption exercise4,42241,905Form 4
2026-05-13Landucci AmyofficerOption exercise4,4224,422Form 4
2026-05-13Kirberger Marcela A.officerOption exercise4,48815,492Form 4
2026-05-13Gomez Tammy LofficerOption exercise3,9603,960Form 4
2026-05-13Kirberger Marcela A.officerOption exercise4,4884,488Form 4
2026-05-13Gomez Tammy LofficerOption exercise3,96015,030Form 4
2026-05-13Harrington Paul SofficerOption exercise3,96022,130Form 4
2026-05-13Hanson Bryan CdirectorOption exercise34,31534,316Form 4
2026-04-30Edwards Shirley AnndirectorOption exercise3,4038,947Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.

As of 2026-09-16 · point-in-time by filed date

Purchase clusters · 2015–2021 (dev)+45 bp/mo vs baseline · up-rate 59.3% vs 57.3% · n=31,607 cluster ticker-weeks
Purchase clusters · 2022–2026 (out-of-sample)+32 bp/mo vs baseline · up-rate 54.0% vs 53.3% · n=27,793

A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).

'24 Q'25 Q'26 Q'26 Qpurchases ▲ / sales ▼ ($ vol)
MemberChamberTypeFiledTradedSize
Alan ArmstrongSenatepurchase2026-07-212026-03-27$1–15K
James French HillHousesale2026-01-232025-12-31$15–50K
Ron WydenSenatesale2025-02-212025-02-06$1–15K
Julie JohnsonHousesale2025-02-122025-01-15$1–15K
Tommy TubervilleSenatepurchase2024-06-142024-05-03$1–15K
Gary PetersSenatesale2024-05-232024-05-14$1–15K

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.